Form 4: Encompass Health EVP Douglas Coltharp Reports Stock Transactions
SEC Form 4 Filing
Encompass Health's EVP & Chief Financial Officer, Douglas Coltharp, reports exercising stock options and selling shares on April 29, 2025.
Summary
- On April 29, 2025, Douglas E. Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, engaged in multiple transactions involving Encompass Health Common Stock.
- Coltharp exercised non-qualified stock options to acquire 16,075 shares at $29.06 and 27,500 shares at $32.94.
- He then sold 26,239 shares at a weighted average price of $114.78, 13,402 shares at $115.51, and 3,934 shares at $116.36.
- Following these transactions, Coltharp directly owns 60,335 shares and indirectly owns 125,631 shares through an irrevocable trust and 65,229 shares through his spouse.
- He also holds 27,694 non-qualified stock options.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's future.
Industry Context
This filing is a routine disclosure of insider transactions, which are common among executives of publicly traded companies. The information is used by investors to gauge management's perspective on the company's stock and future prospects.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly listed companies like Encompass Health.
- Monitoring these transactions is crucial for investors to understand executive sentiment and potential future performance.
- Comparable companies such as Select Medical Holdings Corporation (SEM) and Kindred Healthcare also have similar filings related to insider trading activities.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall impact is likely minimal.
- The reporting person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Key Dates
| Date | Description |
|---|---|
| 02/26/2017 | Date exercisable for 16,075 Non-qualified Stock Options (Right to Buy) |
| 10/28/2019 | Date exercisable for 27,500 Non-qualified Stock Options (Right to Buy) |
| 04/29/2025 | Date of earliest transaction: Exercise of stock options and sale of shares. |
| 04/30/2025 | Date of report. |
| 02/26/2026 | Expiration date for 16,075 Non-qualified Stock Options (Right to Buy) |
| 10/28/2026 | Expiration date for 27,500 Non-qualified Stock Options (Right to Buy) |
Keywords
Encompass Health, EHC, Douglas Coltharp, Stock Options, SEC Form 4, Insider Trading, Beneficial Ownership, Stock Sale, Stock Purchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.